Related Experiment Video

Updated: Aug 9, 2026

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
09:12

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery

Published on: March 27, 2018

Report of the Ad Hoc Committee on Risk Factors for Coronary Artery Bypass Surgery

N T Kouchoukos, P A Ebert, F L Grover

    The Annals of Thoracic Surgery
    |March 1, 1988
    PubMed

    Insights

    The Society of Thoracic Surgeons cautions against using only raw mortality data to assess coronary artery bypass surgery quality. Risk factors must be considered to avoid misleading information and protect high-risk patients.

    Area of Science:

    • Cardiovascular Surgery
    • Healthcare Quality Assessment
    • Medical Data Analysis

    Background:

    • The Society of Thoracic Surgeons expresses significant concern regarding the exclusive use of raw mortality data for evaluating care quality after coronary artery bypass surgery.
    • Current practices may misrepresent the actual quality of care by not accounting for patient-specific risk factors.

    Purpose of the Study:

    • To highlight the inadequacy of using raw mortality data as the sole metric for assessing coronary artery bypass surgery quality.
    • To advocate for a more comprehensive approach to quality assessment that includes risk stratification and other quality indicators.

    Main Methods:

    • Analysis of the implications of using unadjusted mortality data in healthcare quality evaluation.
    • Review of the Society's commitment to accurate public information on coronary artery surgery.

    Main Results:

    • Raw mortality data, when used in isolation, is deemed inappropriate and misleading for determining surgical quality.
    • Failure to consider risk factors can adversely impact the care provided to high-risk cardiac surgical patients.

    Conclusions:

    • The Society of Thoracic Surgeons believes that data from the Health Care Financing Administration (HCFA) is insufficient as a sole index of quality for coronary artery bypass surgery.
    • A nuanced approach incorporating risk factors and diverse quality indices is essential for accurate patient care assessment and public information.

    More Related Videos

    Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement08:50

    Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

    Published on: March 26, 2018

    Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis07:51

    Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

    Published on: September 26, 2018

    Related Concept Videos

    Coronary Artery Disease I: Introduction01:30

    Coronary Artery Disease I: Introduction

    Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
    Coronary Artery Disease IV: Preventive Measures01:26

    Coronary Artery Disease IV: Preventive Measures

    Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
    Coronary Artery Disease V: Interprofessional Care01:27

    Coronary Artery Disease V: Interprofessional Care

    Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
    Acute Coronary Syndrome III: Diagnostic Studies01:30

    Acute Coronary Syndrome III: Diagnostic Studies

    Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
    Peripheral Artery Disease V: Postoperative Nursing Management01:23

    Peripheral Artery Disease V: Postoperative Nursing Management

    During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...